WallStreetZenWallStreetZen

Sectors & IndustriesConsumer DefensivePharmaceutical Retailers
Best Pharmaceutical Retailer Stocks to Buy Now (2024)
Top pharmaceutical retailer stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

Industry: Pharmaceutical Retailers
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
WBA
WALGREENS BOOTS ALLIANCE INC
United States
$18.13B862,375,52731.92%68.08%Net SellingNet Selling
HITI
HIGH TIDE INC
Canada (Federal Level)
$161.83M78,557,2814.54%0.00%
MEDS
TRXADE HEALTH INC
United States
$11.51M1,205,0080.02%99.98%
PETS
PETMED EXPRESS INC
United States
$102.35M21,147,00650.29%49.71%Net Buying
SSY
SUNLINK HEALTH SYSTEMS INC
United States
$5.14M7,040,60310.28%89.72%Net Buying
CJJD
CHINA JO-JO DRUGSTORES INC
China
$5.57M1,682,8610.76%99.24%
YI
111 INC
China
$85.79M169,883,1751.15%0.00%
LFLY
LEAFLY HOLDINGS INC
United States
$6.60M2,177,7212.58%97.42%Net Buying
BIMI
BIMI HOLDINGS INC
China
$21.08M11,589,5690.01%99.99%Net BuyingNet Buying

Pharmaceutical Retailer Stocks FAQ

What are the best pharmaceutical retailer stocks to buy right now in Mar 2024?

According to Zen Score, the 3 best drug store stocks to buy right now are:

1. Walgreens Boots Alliance (NASDAQ:WBA)


Walgreens Boots Alliance (NASDAQ:WBA) is the top pharmaceutical retailer stock with a Zen Score of 43, which is 21 points higher than the pharmaceutical retailer industry average of 22. It passed 16 out of 38 due diligence checks and has strong fundamentals. Walgreens Boots Alliance has seen its stock lose -36.19% over the past year, overperforming other pharmaceutical retailer stocks by 33 percentage points.

Walgreens Boots Alliance has an average 1 year price target of $24.14, an upside of 14.86% from Walgreens Boots Alliance's current stock price of $21.02.

Walgreens Boots Alliance stock has a consensus Hold recommendation according to Wall Street analysts. Of the 7 analysts covering Walgreens Boots Alliance, 14.29% have issued a Strong Buy rating, 0% have issued a Buy, 57.14% have issued a hold, while 14.29% have issued a Sell rating, and 14.29% have issued a Strong Sell.

2. High Tide (NASDAQ:HITI)


High Tide (NASDAQ:HITI) is the second best pharmaceutical retailer stock with a Zen Score of 25, which is 3 points higher than the pharmaceutical retailer industry average of 22. It passed 8 out of 33 due diligence checks and has weak fundamentals. High Tide has seen its stock return 79.13% over the past year, overperforming other pharmaceutical retailer stocks by 148 percentage points.

High Tide has an average 1 year price target of $4.50, an upside of 118.45% from High Tide's current stock price of $2.06.

High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Trxade Health (NASDAQ:MEDS)


Trxade Health (NASDAQ:MEDS) is the third best pharmaceutical retailer stock with a Zen Score of 23, which is 1 points higher than the pharmaceutical retailer industry average of 22. It passed 8 out of 38 due diligence checks and has weak fundamentals. Trxade Health has seen its stock return 39.93% over the past year, overperforming other pharmaceutical retailer stocks by 109 percentage points.

What are the pharmaceutical retailer stocks with highest dividends?

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

1. Trxade Health (NASDAQ:MEDS)


Trxade Health (NASDAQ:MEDS) has an annual dividend yield of 83.77%, which is 49 percentage points higher than the pharmaceutical retailer industry average of 34.74%.

Trxade Health's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Walgreens Boots Alliance (NASDAQ:WBA)


Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 8.04%, which is -27 percentage points lower than the pharmaceutical retailer industry average of 34.74%. Walgreens Boots Alliance's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Walgreens Boots Alliance's dividend has not shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of 290.9% indicates that its high dividend yield might not be sustainable for the long-term.

Why are pharmaceutical retailer stocks up?

Pharmaceutical retailer stocks were up 0.55% in the last day, and down -18.46% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are up.

What are the most undervalued pharmaceutical retailer stocks?

Based on WallStreetZen's Valuation Score, the 2 most undervalued pharmaceutical retailer stocks right now are:

1. Walgreens Boots Alliance (NASDAQ:WBA)


Walgreens Boots Alliance (NASDAQ:WBA) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Walgreens Boots Alliance has a valuation score of 57, which is 43 points higher than the pharmaceutical retailer industry average of 14. It passed 4 out of 7 valuation due diligence checks.

Walgreens Boots Alliance's stock has dropped -36.19% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 33 percentage points.

2. Petmed Express (NASDAQ:PETS)


Petmed Express (NASDAQ:PETS) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Petmed Express has a valuation score of 43, which is 29 points higher than the pharmaceutical retailer industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Petmed Express's stock has dropped -69.58% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -1 percentage points.

Are pharmaceutical retailer stocks a good buy now?

33.33% of pharmaceutical retailer stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical retailer stocks to rise by 25.87% over the next year.

What is the average p/e ratio of the pharmaceutical retailers industry?

The average P/E ratio of the pharmaceutical retailers industry is 31.03x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.